Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Cancer Biomarkers Adoption Is Driving Growth |
Jul 2008 | £2,370 | 100% |
| Salient Review Colorectal Cancer Advances in Blood Biomarkers, 2011 |
Oct 2011 | £320 | 99% |
| Biomarkers in Breast Cancer 2011 |
Jan 2011 | £1,500 | 99% |
| Cancer Biomarkers Enhancing diagnostic, therapeutic and developmental strategies |
May 2006 | £1,390 | 99% |
| Salient Review Non-Small Cell Lung Cancer Advances in Blood Biomarkers, 2011 |
Oct 2011 | £320 | 99% |
| VEGF Inhibition: Therapy-Indicating and Prognostic Biomarkers 2011 |
Oct 2011 | £950 | 98% |
| Biomarkers in Cancer Research High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth |
Sep 2010 | £2,215 | 98% |
| Global Cancer Biomarkers Market (2010 - 2015) | May 2010 | £2,940 | 98% |
| Cancer Biomarkers: Players, products and prospects (Volume I) | Aug 2008 | £595 | 98% |
| Targeting Cancer Stem Cells Therapeutic Strategies, Pipeline, Biomarkers and Opportunities (2010) |
Jan 2010 | £1,599 | 97% |
| Biomarkers: A Market Briefing A Market Briefing |
Jan 2007 | £1,260 | 97% |
| Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects | Aug 2008 | £1,495 | 97% |
| Cell Culture The World Market for Media, Sera, and Reagents |
Jan 2007 | £2,465 | 97% |
| Expanding Applications of Personalized Medicine Use of Biomarkers in Prognostic, Predictive and Pharmacogenetic Tests in a Targeted Approach |
Aug 2009 | £2,425 | 97% |
| Commercializing Biomarkers in Therapeutic and Diagnostic Applications | May 2011 | £2,020 | 97% |
| Personalized Medicine Market Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics |
Dec 2010 | £2,215 | 97% |
| Convergence of Biomarkers and Diagnostics, The Therapy Area Analyses, Key Products and Future Trends |
Apr 2008 | £2,425 | 96% |
| Biomarker Technology Platforms for Cancer Diagnoses and Therapies | Sep 2011 | £2,150 | 95% |
| Molecular Diagnostics in Cancer Testing | Jul 2011 | £2,150 | 95% |
| Biomarkers The Expanding Global Market |
Jan 2007 | £2,760 | 95% |
| Biomarkers (2 parts) Technologies, Markets and Companies |
Jan 2012 | £3,240 | 95% |
| Orion Genomics Product Pipeline Analysis | Jan 2009 | £475 | 95% |
| Cancer Personalized Medicine 2008 | Jul 2008 | £2,425 | 94% |
| Biomarkers - Advanced Technologies and Global Market 2009 - 2014 |
Sep 2009 | £2,940 | 94% |
| Personalized Medicine 2010 Assessing the Opportunities and Challenges in Commercializing Companion |
May 2010 | £1,580 | 94% |
| Biomarkers: Technological and Commercial Outlook 2011-2021 discovering the pharma and diagnostics opportunities |
Jun 2011 | £1,499 | 94% |
| Cancer Profiling and Pathways Technologies and Global Markets |
Sep 2010 | £3,065 | 94% |
| Qiagen N.V. (QIA) Product Pipeline Analysis |
Aug 2011 | £475 | 93% |
| Biomarkers | Aug 2011 | £3,035 | 93% |
| Cytogenetics Technologies, Markets and Companies |
Jan 2012 | £1,620 | 93% |
